Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Sefaxersen sodium by F. Hoffmann-La Roche for Geographic Atrophy: Likelihood of Approval
Sefaxersen sodium is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Geographic Atrophy. According to...
Satralizumab by F. Hoffmann-La Roche for Myasthenia Gravis: Likelihood of Approval
Satralizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Myasthenia Gravis. According to GlobalData,...
Alectinib by F. Hoffmann-La Roche for Inflammatory Myofibroblastic Tumor (IMT): Likelihood of Approval
Alectinib is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Inflammatory Myofibroblastic Tumor (IMT). According...
Atezolizumab by F. Hoffmann-La Roche for Uterine Cancer: Likelihood of Approval
Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Uterine Cancer. According to GlobalData,...
Atezolizumab by F. Hoffmann-La Roche for Glioblastoma Multiforme (GBM): Likelihood of Approval
Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Glioblastoma Multiforme (GBM). According to...
RG-6333 by F. Hoffmann-La Roche for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval
RG-6333 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for B-Cell Non-Hodgkin Lymphoma. According to...
Astegolimab by F. Hoffmann-La Roche for Chronic Obstructive Pulmonary Disease (COPD): Likelihood of Approval
Astegolimab is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Chronic Obstructive Pulmonary Disease (COPD)....
Atezolizumab by F. Hoffmann-La Roche for Hepatocellular Carcinoma: Likelihood of Approval
Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Hepatocellular Carcinoma. According to GlobalData,...
Obinutuzumab by F. Hoffmann-La Roche for Nephrotic Syndrome: Likelihood of Approval
Obinutuzumab is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Nephrotic Syndrome. According to GlobalData,...
RO-7308480 by F. Hoffmann-La Roche for Social Anxiety Disorder (SAD/Social Phobia): Likelihood of Approval
RO-7308480 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Social Anxiety Disorder (SAD/Social Phobia)....
Selnoflast by F. Hoffmann-La Roche for Asthma: Likelihood of Approval
Selnoflast is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Asthma. According to GlobalData, Phase...
RO-7200394 by F. Hoffmann-La Roche for Macular Edema: Likelihood of Approval
RO-7200394 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Macular Edema. According to GlobalData,...
Tominersen by F. Hoffmann-La Roche for Huntington Disease: Likelihood of Approval
Tominersen is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Huntington Disease. According to GlobalData,...
Vopikitug by F. Hoffmann-La Roche for Non-Small Cell Lung Cancer: Likelihood of Approval
Vopikitug is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Non-Small Cell Lung Cancer. According...
Vopikitug by F. Hoffmann-La Roche for Esophageal Cancer: Likelihood of Approval
Vopikitug is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Esophageal Cancer. According to GlobalData,...
Vopikitug by F. Hoffmann-La Roche for Head And Neck Cancer: Likelihood of Approval
Vopikitug is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Head And Neck Cancer. According...
Vopikitug by F. Hoffmann-La Roche for Solid Tumor: Likelihood of Approval
Vopikitug is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Solid Tumor. According to GlobalData,...
Vopikitug by F. Hoffmann-La Roche for Breast Cancer: Likelihood of Approval
Vopikitug is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Breast Cancer. According to GlobalData,...
Vopikitug by F. Hoffmann-La Roche for Ovarian Cancer: Likelihood of Approval
Vopikitug is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Ovarian Cancer. According to GlobalData,...
RG-6457 by F. Hoffmann-La Roche for Solid Tumor: Likelihood of Approval
RG-6457 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Solid Tumor. According to GlobalData,...